Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 175 clinical trials
The Agreement of hrHPV Detections Between Vaginal Self-sampling and Physician Sampling

Hygeia Touch Inc. has developed a safe and comfortable vaginal self-sampling device "Hygeia Touch Self Sampling Kit for Women" to self-collect the vaginal samples for high-risk Human Papillomavirus (hrHPV) detection. This clinical trial aimed to evaluate the agreement of hrHPV detections between vaginal self-sampling using "Hygeia Touch Self Sampling Kit …

cervical disease
intraepithelial neoplasia
cin 2
human papillomavirus
hysterectomy
  • 0 views
  • 19 Feb, 2024
  • 3 locations
Evaluate the Efficacy Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

This study is designed to evaluate the vaccine efficacy, immunogenicity and safety of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Subjects Aged 20-45 Years .

cervical cancer
intrauterine device (iud)
human papillomavirus
cervical cap
oral contraceptives
  • 0 views
  • 19 Feb, 2024
  • 1 location
Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments

Human papilloma virus (HPV) is responsible of the most common sexually transmitted infection. It can cause severe cancer lesions, of the cervix, vulva, vagina, penis and oropharynx.

severe cancer
cervical cancer
sexually transmitted infection
human papillomavirus
hysterectomy
  • 0 views
  • 19 Feb, 2024
  • 1 location
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

The objective of this trial is to study the efficacy of treatment of human papilloma virus (HPV) related oropharyngeal cancer with chemotherapy followed by Transoral Robotic Surgery (TORS) as definitive treatment.

human papillomavirus
carcinoma
chemo-radiotherapy
karnofsky performance status
absolute neutrophil count
  • 0 views
  • 19 Feb, 2024
  • 1 location
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

This is a Phase II treatment, non-randomized, open label clinical trial to study the efficacy of the Cetuximab when administered as single agent in recurrent/ metastatic head and neck squamous cell carcinoma after the failure or intolerance of immuno-oncology or immuno-oncology combined with chemotherapy.

measurable disease
squamous cell carcinoma of head and neck
metastatic squamous cell carcinoma
cancer of the head
pd-1 inhibitor
  • 0 views
  • 19 Feb, 2024
  • 1 location